We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
Turnover
31.08%
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
+24.48%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.92%
AUM
$72.6B
AUM Growth
+$8.69B
(+14%)
Cap. Flow
+$958M
Cap. Flow % of AUM
Cap. Flow %
1.32%
Top 10 Holdings %
Top 10 Hldgs %
12.01%
Holding
3,761
New
548
Increased
1,084
Reduced
1,502
Closed
621
Avg Time Held
3.5
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.58% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
Pennant Group
PNTG
$1.48B
| $1.78M | ﹤0.01% |
48,191
-17,995
| -27% | -$588K |
2023 Q1
13 quarters
|
|
2027
Princeton Bancorp
BPRN
$306M
| $1.78M | ﹤0.01% |
46,786
+9,763
| +26% | +$349K |
2018 Q3
31 quarters
|
|
2028
Neuropace
NPCE
$451M
| $1.77M | ﹤0.01% |
111,699
-62,612
| -36% | -$1.01M |
2022 Q2
16 quarters
|
|
2029
Monro
MNRO
$443M
| $1.77M | ﹤0.01% |
+103,679
| New | +$1.7M |
2026 Q2
0 quarters
|
|
2030
Franklin Covey
FC
$214M
| $1.77M | ﹤0.01% |
72,303
-14,000
| -16% | -$319K |
2013 Q2
52 quarters
|
|
2031
Direxion Daily TSLA Bear 1X ETF
TSLS
$46.5M
| $1.77M | ﹤0.01% |
+34,600
| New | +$1.93M |
2026 Q2
0 quarters
|
|
2032
Lineage Inc
LINE
$7.99B
| $1.77M | ﹤0.01% |
40,900
-251,800
| -86% | -$9.9M |
2024 Q3
7 quarters
|
|
2033
Alliance Laundry Holdings
ALH
$4.26B
| $1.77M | ﹤0.01% |
66,700
-140,600
| -68% | -$3.51M |
2025 Q4
2 quarters
|
|
2034
Schwab 1000 Index ETF
SCHK
$5.73B
| $1.77M | ﹤0.01% |
+49,000
| New | +$1.71M |
2026 Q2
0 quarters
|
|
2035
Upbound Group
UPBD
$1.01B
| $1.77M | ﹤0.01% |
83,200
+19,300
| +30% | +$361K |
2026 Q1
1 quarter
|
|
2036
Lineage Cell Therapeutics
LCTX
$249M
| $1.76M | ﹤0.01% |
1,344,829
-780,271
| -37% | -$1.08M |
2023 Q2
12 quarters
|
|
2037
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.69B
| $1.76M | ﹤0.01% |
44,609
+30,809
| +223% | +$1.22M |
2023 Q4
10 quarters
|
|
2038
Loar Holdings
LOAR
$6.07B
| $1.76M | ﹤0.01% |
21,800
-33,300
| -60% | -$2.12M |
2025 Q4
2 quarters
|
|
2039
Greene County Bancorp
GCBC
$613M
| $1.75M | ﹤0.01% |
52,200
+1,200
| +2% | +$30.9K |
2024 Q2
8 quarters
|
|
2040
Advantage Solutions
ADV
$389M
| $1.75M | ﹤0.01% |
40,531
+7,056
| +21% | +$250K |
2022 Q1
17 quarters
|
|
2041
Driven Brands
DRVN
$1.95B
| $1.74M | ﹤0.01% |
+125,100
| New | +$1.65M |
2026 Q2
0 quarters
|
|
2042
World Kinect Corp
WKC
$1.87B
| $1.74M | ﹤0.01% |
52,886
+6,400
| +14% | +$178K |
2025 Q4
2 quarters
|
|
2043
Aspen Aerogels
ASPN
$451M
| $1.74M | ﹤0.01% |
+274,392
| New | +$1.35M |
2026 Q2
0 quarters
|
|
2044
Vanguard Dividend Appreciation ETF
VIG
$115B
| $1.74M | ﹤0.01% |
7,352
-2,348
| -24% | -$539K |
2025 Q3
3 quarters
|
|
2045
Farmers & Merchants Bancorp
FMAO
$494M
| $1.74M | ﹤0.01% |
+56,881
| New | +$1.57M |
2026 Q2
0 quarters
|
|
2046
Tucows
TCX
$133M
| $1.74M | ﹤0.01% |
128,951
-6,900
| -5% | -$105K |
2013 Q2
52 quarters
|
|
2047
Voyager Therapeutics
VYGR
$115M
| $1.73M | ﹤0.01% |
495,236
-82,788
| -14% | -$314K |
2022 Q2
16 quarters
|
|
2048
Aquestive Therapeutics
AQST
$518M
| $1.73M | ﹤0.01% |
+416,248
| New | +$1.75M |
2026 Q2
0 quarters
|
|
2049
Chord Energy
CHRD
$8.23B
| $1.73M | ﹤0.01% |
15,094
-93,058
| -86% | -$12.6M |
2024 Q1
9 quarters
|
|
2050
ImmuCell
ICCC
$94.8M
| $1.72M | ﹤0.01% |
171,089
+19,300
| +13% | +$170K |
2013 Q2
52 quarters
|
|
Similar funds
Jim Simons's Q2 2026 Portfolio in Review
As of Q2 2026, Jim Simons held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Jim Simons added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Jim Simons's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Jim Simons fully exited Applovin in Q2 2026, selling an estimated $174M.
- Jim Simons's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Jim Simons opened 548 new positions and closed 621 in Q2 2026.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.